Details of the Drug Formulations

General Information of Drug (ID: DM0QZBN)

Drug Name
Ibandronate Drug Info
Synonyms
BFQ; Acid ibandronico; Ibandronic Acid; Bisphosphonate 2; R484; RPR 102289A; Bondronat (TN); Boniva (TN); Bonviva (TN); Ibandronic acid (INN); Ibandronic acid [INN:BAN]; RPR-102289A; Ibandronic acid, sodium salt, monohydrate; Roche brand of ibandronic acid, sodium salt, monohydrate; [1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl]phosphonic acid; [1-HYDROXY-3-(METHYL-PENTYL-AMINO)-1-PHOSPHONO-PROPYL]-PHOSPHONIC ACID; (1-Hydroxy-3-(methylpentylamino)propylidene)diphosphonic acid; (1-hydroxy-3-(methylpentylamino)propylidene)bisphosphonate; 1-hydroxy-3-(methylpentylamino)propylidenebisphosphonate
Indication
Disease Entry ICD 11 Status REF
Osteoporosis FB83.0 Approved [1] , [2]
Therapeutic Class
Bone Density Conservation Agents
Cross-matching ID
PubChem CID
60852
CAS Number
114084-78-5
TTD ID
D08SJZ
ACDINA ID
D00319

Full List of Drug Formulations Containing This Drug

Ibandronic acid 150 mg tablet
Company Formulation ID FDA Description
Dr Reddy's Laboratories F10070 Lactose monohydrate; Sodium stearyl fumarate; Ammonia; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Croscarmellose sodium; Crospovidone; Polyethylene glycol 400; Povidone; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses; Shellac
Physicians Total Care F10064 Stearic acid; Lactose monohydrate; Talc; Titanium dioxide; Water; Crospovidone; Polyethylene glycol 6000; Povidone; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses
Aurobindo Pharma F10067 Sodium stearyl fumarate; Talc; Titanium dioxide; Triacetin; Crospovidone; Povidone; Silicon dioxide; Hypromellose 2910 (5 mpa.s); Microcrystalline cellulose
AvKARE F10069 Sodium stearyl fumarate; Sorbitol; Talc; Titanium dioxide; Croscarmellose sodium; Polyvinyl alcohol; Silicon dioxide; Cellulose, microcrystalline
Alvogen F10065 Lactose monohydrate; Sodium stearyl fumarate; Ferric oxide yellow; Titanium dioxide; Water; Crospovidone; Silicon dioxide; Hypromellose, unspecified; Microcrystalline cellulose; Polyethylene glycol, unspecified; Povidone, unspecified
Genentech F10071 Stearic acid; Lactose monohydrate; Talc; Titanium dioxide; Polyethylene glycol 6000; Silicon dioxide; Crospovidone (15 mpa.s at 5%); Hypromellose, unspecified; Microcrystalline cellulose; Povidone k25
Actavis Pharma F10068 Sodium stearyl fumarate; Sorbitol; Talc; Titanium dioxide; Croscarmellose sodium; Silicon dioxide; Cellulose, microcrystalline; Polyethylene glycol 35000; Polyvinyl alcohol, unspecified
Macleods Pharmaceuticals F10063 Lactose monohydrate; Magnesium stearate; Talc; Titanium dioxide; Crospovidone; Povidone; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycol
Mylan Pharamceuticals F10061 Lactose monohydrate; Magnesium stearate; Ammonia; Ferrosoferric oxide; Titanium dioxide; Crospovidone; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Polyethylene glycols; Povidones; Shellac
Apotex F10062 Magnesium stearate; Water; Crospovidone; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycol 8000
Golden State Medical Supply F10066 Magnesium stearate; Water; Silicon dioxide; Crospovidone (15 mpa.s at 5%); Hypromellose, unspecified; Microcrystalline cellulose; Polyethylene glycol 8000
------------------------------------------------------------------------------------
⏷ Show the Full List of 11 Formulation(s)

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3059).
2 Efficacy of bisphosphonates in reducing fracture risk in postmenopausal osteoporosis. Am J Med. 2009 Feb;122(2 Suppl):S14-21.